{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:53:41Z","timestamp":1786985621431,"version":"build-2736575974"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020581","name":"Fondazione AIRC per la ricerca sul cancro ETS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020581","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002661","name":"FRS-FNRS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022434","name":"WELBIO","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022434","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013845","name":"Fondation contre le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013845","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.canlet.2025.217512","type":"journal-article","created":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T10:56:13Z","timestamp":1738407373000},"page":"217512","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Acidosis overrides molecular heterogeneity to shape therapeutically targetable metabolic phenotypes in colon cancers"],"prefix":"10.1016","volume":"613","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6204-8347","authenticated-orcid":false,"given":"Elena","family":"Richiardone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4888-7857","authenticated-orcid":false,"given":"Maria Virginia","family":"Giolito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rim","family":"Al Roumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Ambroise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9956-1737","authenticated-orcid":false,"given":"Romain","family":"Boidot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0914-6578","authenticated-orcid":false,"given":"Bernhard","family":"Drotleff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1547-1705","authenticated-orcid":false,"given":"Bart","family":"Ghesqui\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4383-6882","authenticated-orcid":false,"given":"Barbara","family":"Lupo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6379-3365","authenticated-orcid":false,"given":"Livio","family":"Trusolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Bardelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1318-2494","authenticated-orcid":false,"given":"Sabrina","family":"Arena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Feron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8795-9131","authenticated-orcid":false,"given":"Cyril","family":"Corbet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.canlet.2025.217512_bib1","first-page":"233","article-title":"Colorectal cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"issue":"8","key":"10.1016\/j.canlet.2025.217512_bib2","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/s41571-021-00495-z","article-title":"Precision oncology in metastatic colorectal cancer - from biology to medicine","volume":"18","author":"Di Nicolantonio","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.canlet.2025.217512_bib3","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.annonc.2022.10.003","article-title":"Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"34","author":"Cervantes","year":"2023","journal-title":"Ann. Oncol."},{"issue":"11","key":"10.1016\/j.canlet.2025.217512_bib4","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1038\/nm.3967","article-title":"The consensus molecular subtypes of colorectal cancer","volume":"21","author":"Guinney","year":"2015","journal-title":"Nat Med"},{"issue":"7","key":"10.1016\/j.canlet.2025.217512_bib5","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41389-021-00342-x","article-title":"Tumour heterogeneity and evolutionary dynamics in colorectal cancer","volume":"10","author":"Chan","year":"2021","journal-title":"Oncogenesis"},{"issue":"12","key":"10.1016\/j.canlet.2025.217512_bib6","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1038\/nbt.2038","article-title":"Single-cell dissection of transcriptional heterogeneity in human colon tumors","volume":"29","author":"Dalerba","year":"2011","journal-title":"Nat. Biotechnol."},{"issue":"7","key":"10.1016\/j.canlet.2025.217512_bib7","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/s41588-022-01100-4","article-title":"Single-cell and bulk transcriptome sequencing identifies two epithelial tumor cell states and refines the consensus molecular classification of colorectal cancer","volume":"54","author":"Joanito","year":"2022","journal-title":"Nat. Genet."},{"issue":"7702","key":"10.1016\/j.canlet.2025.217512_bib8","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41586-018-0024-3","article-title":"Intra-tumour diversification in colorectal cancer at the single-cell level","volume":"556","author":"Roerink","year":"2018","journal-title":"Nature"},{"issue":"24","key":"10.1016\/j.canlet.2025.217512_bib9","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adf5464","article-title":"Single-cell and spatial transcriptome analysis reveals the cellular heterogeneity of liver metastatic colorectal cancer","volume":"9","author":"Wang","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.canlet.2025.217512_bib10","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.86032","article-title":"Comprehensive characterization of tumor microenvironment in colorectal cancer via molecular analysis","volume":"12","author":"Wu","year":"2023","journal-title":"Elife"},{"issue":"5947","key":"10.1016\/j.canlet.2025.217512_bib11","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1126\/science.1174229","article-title":"Glucose deprivation contributes to the development of KRAS pathway mutations in tumor cells","volume":"325","author":"Yun","year":"2009","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.canlet.2025.217512_bib12","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/s41551-019-0416-1","article-title":"PET imaging of occult tumours by temporal integration of tumour-acidosis signals from pH-sensitive (64)Cu-labelled polymers","volume":"4","author":"Huang","year":"2020","journal-title":"Nat. Biomed. Eng."},{"issue":"1","key":"10.1016\/j.canlet.2025.217512_bib13","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1038\/s41467-020-16814-4","article-title":"Exploiting metabolic acidosis in solid cancers using a tumor-agnostic pH-activatable nanoprobe for fluorescence-guided surgery","volume":"11","author":"Voskuil","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2025.217512_bib14","doi-asserted-by":"crossref","DOI":"10.1038\/s41551-016-0006","article-title":"A Transistor-like pH nanoprobe for tumour detection and image-guided surgery","volume":"1","author":"Zhao","year":"2016","journal-title":"Nat. Biomed. Eng."},{"issue":"3","key":"10.1016\/j.canlet.2025.217512_bib15","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1038\/s44319-024-00089-7","article-title":"Tumor acidosis-induced DNA damage response and tetraploidy enhance sensitivity to ATM and ATR inhibitors","volume":"25","author":"Aubert","year":"2024","journal-title":"EMBO Rep."},{"issue":"2","key":"10.1016\/j.canlet.2025.217512_bib16","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0027-5107(92)90235-T","article-title":"Clastogenicity of low pH to various cultured mammalian cells","volume":"268","author":"Morita","year":"1992","journal-title":"Mutat. Res."},{"issue":"12","key":"10.1016\/j.canlet.2025.217512_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1000293","article-title":"The genomic analysis of lactic acidosis and acidosis response in human cancers","volume":"4","author":"Chen","year":"2008","journal-title":"PLoS Genet."},{"issue":"10","key":"10.1016\/j.canlet.2025.217512_bib18","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1007\/s00109-020-01959-y","article-title":"The acidic tumor microenvironment drives a stem-like phenotype in melanoma cells","volume":"98","author":"Andreucci","year":"2020","journal-title":"J. Mol. Med. (Berl.)"},{"key":"10.1016\/j.canlet.2025.217512_bib19","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3389\/fonc.2019.00159","article-title":"Therapeutic targeting of cancer stem cells: integrating and exploiting the acidic niche","volume":"9","author":"Vander Linden","year":"2019","journal-title":"Front. Oncol."},{"issue":"16","key":"10.1016\/j.canlet.2025.217512_bib20","doi-asserted-by":"crossref","first-page":"3938","DOI":"10.1158\/0008-5472.CAN-11-3881","article-title":"Chronic autophagy is a cellular adaptation to tumor acidic pH microenvironments","volume":"72","author":"Wojtkowiak","year":"2012","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.canlet.2025.217512_bib21","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41467-019-14262-3","article-title":"TGFbeta2-induced formation of lipid droplets supports acidosis-driven EMT and the metastatic spreading of cancer cells","volume":"11","author":"Corbet","year":"2020","journal-title":"Nat. Commun."},{"issue":"19","key":"10.1016\/j.canlet.2025.217512_bib22","doi-asserted-by":"crossref","first-page":"5507","DOI":"10.1158\/0008-5472.CAN-14-0705","article-title":"The SIRT1\/HIF2alpha axis drives reductive glutamine metabolism under chronic acidosis and alters tumor response to therapy","volume":"74","author":"Corbet","year":"2014","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.canlet.2025.217512_bib23","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.cmet.2016.07.003","article-title":"Acidosis drives the reprogramming of fatty acid metabolism in cancer cells through changes in mitochondrial and histone acetylation","volume":"24","author":"Corbet","year":"2016","journal-title":"Cell Metab."},{"issue":"8","key":"10.1016\/j.canlet.2025.217512_bib24","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1002\/ijc.34404","article-title":"Chronic acidosis rewires cancer cell metabolism through PPARalpha signaling","volume":"152","author":"Rolver","year":"2023","journal-title":"Int. J. Cancer"},{"issue":"4","key":"10.1016\/j.canlet.2025.217512_bib25","first-page":"759","article-title":"A colon cancer cell line (LIM1215) derived from a patient with inherited nonpolyposis colorectal cancer","volume":"74","author":"Whitehead","year":"1985","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.canlet.2025.217512_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217091","article-title":"MCT1-dependent lactate recycling is a metabolic vulnerability in colorectal cancer cells upon acquired resistance to anti-EGFR targeted therapy","volume":"598","author":"Richiardone","year":"2024","journal-title":"Cancer Lett."},{"issue":"6","key":"10.1016\/j.canlet.2025.217512_bib27","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nmeth.3393","article-title":"MS-DIAL: data-independent MS\/MS deconvolution for comprehensive metabolome analysis","volume":"12","author":"Tsugawa","year":"2015","journal-title":"Nat. Methods"},{"issue":"1","key":"10.1016\/j.canlet.2025.217512_bib28","doi-asserted-by":"crossref","first-page":"7495","DOI":"10.1038\/s41467-024-51909-2","article-title":"XENTURION is a population-level multidimensional resource of xenografts and tumoroids from metastatic colorectal cancer patients","volume":"15","author":"Leto","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2025.217512_bib29","doi-asserted-by":"crossref","first-page":"7002","DOI":"10.1038\/ncomms8002","article-title":"The molecular landscape of colorectal cancer cell lines unveils clinically actionable kinase targets","volume":"6","author":"Medico","year":"2015","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.canlet.2025.217512_bib30","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1158\/0008-5472.CAN-17-1923","article-title":"Results from the European prospective investigation into cancer and nutrition link vitamin B6 catabolism and lung cancer risk","volume":"78","author":"Zuo","year":"2018","journal-title":"Cancer Res."},{"issue":"11\u201312","key":"10.1016\/j.canlet.2025.217512_bib31","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.nut.2009.04.008","article-title":"In vitro studies on the inhibition of colon cancer by butyrate and carnitine","volume":"25","author":"Roy","year":"2009","journal-title":"Nutrition"},{"issue":"1","key":"10.1016\/j.canlet.2025.217512_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/omi.2014.0116","article-title":"Developing urinary metabolomic signatures as early bladder cancer diagnostic markers","volume":"19","author":"Shen","year":"2015","journal-title":"OMICS"},{"issue":"1","key":"10.1016\/j.canlet.2025.217512_bib33","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/2049-3002-1-23","article-title":"Acidosis induces reprogramming of cellular metabolism to mitigate oxidative stress","volume":"1","author":"Lamonte","year":"2013","journal-title":"Cancer Metab"},{"issue":"7","key":"10.1016\/j.canlet.2025.217512_bib34","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/nrc3298","article-title":"Evolutionary dynamics of carcinogenesis and why targeted therapy does not work","volume":"12","author":"Gillies","year":"2012","journal-title":"Nat. Rev. Cancer"},{"issue":"10","key":"10.1016\/j.canlet.2025.217512_bib35","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nrc.2017.77","article-title":"Tumour acidosis: from the passenger to the driver's seat","volume":"17","author":"Corbet","year":"2017","journal-title":"Nat. Rev. Cancer"},{"issue":"12","key":"10.1016\/j.canlet.2025.217512_bib36","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/s41568-023-00628-9","article-title":"How protons pave the way to aggressive cancers","volume":"23","author":"Swietach","year":"2023","journal-title":"Nat. Rev. Cancer"},{"issue":"7","key":"10.1016\/j.canlet.2025.217512_bib37","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1002\/cam4.1032","article-title":"Tris-base buffer: a promising new inhibitor for cancer progression and metastasis","volume":"6","author":"Ibrahim-Hashim","year":"2017","journal-title":"Cancer Med."},{"key":"10.1016\/j.canlet.2025.217512_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.979154","article-title":"Tumor acidity: from hallmark of cancer to target of treatment","volume":"12","author":"Bogdanov","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canlet.2025.217512_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122041","article-title":"Targeting cancer cells in acidosis with conjugates between the carnitine palmitoyltransferase 1 inhibitor etomoxir and pH (low) insertion peptides","volume":"624","author":"Deskeuvre","year":"2022","journal-title":"Int J Pharm"},{"issue":"8","key":"10.1016\/j.canlet.2025.217512_bib40","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/j.cmet.2021.05.016","article-title":"Peroxidation of n-3 and n-6 polyunsaturated fatty acids in the acidic tumor environment leads to ferroptosis-mediated anticancer effects","volume":"33","author":"Dierge","year":"2021","journal-title":"Cell Metab."},{"key":"10.1016\/j.canlet.2025.217512_bib41","doi-asserted-by":"crossref","first-page":"3550","DOI":"10.1038\/ncomms4550","article-title":"Acidosis overrides oxygen deprivation to maintain mitochondrial function and cell survival","volume":"5","author":"Khacho","year":"2014","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.canlet.2025.217512_bib42","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1158\/0008-5472.CAN-11-2076","article-title":"Functional interaction between responses to lactic acidosis and hypoxia regulates genomic transcriptional outputs","volume":"72","author":"Tang","year":"2012","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.canlet.2025.217512_bib43","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.bbrc.2018.06.092","article-title":"Lactic acid induces lactate transport and glycolysis\/OXPHOS interconversion in glioblastoma","volume":"503","author":"Duan","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"26","key":"10.1016\/j.canlet.2025.217512_bib44","doi-asserted-by":"crossref","first-page":"40621","DOI":"10.18632\/oncotarget.9746","article-title":"Lactic acidosis switches cancer cells from aerobic glycolysis back to dominant oxidative phosphorylation","volume":"7","author":"Wu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2025.217512_bib45","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.bbrc.2023.05.097","article-title":"Lactic acidosis switches cancer cells from dependence on glycolysis to OXPHOS and renders them highly sensitive to OXPHOS inhibitors","volume":"671","author":"Zeng","year":"2023","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"10","key":"10.1016\/j.canlet.2025.217512_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110493","article-title":"CRISPR-Cas9 screen identifies oxidative phosphorylation as essential for cancer cell survival at low extracellular pH","volume":"38","author":"Michl","year":"2022","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.canlet.2025.217512_bib47","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3390\/organoids1010008","article-title":"Metabolic studies in organoids: current applications, opportunities and challenges","volume":"1","author":"Richiardone","year":"2022","journal-title":"Organoids"},{"issue":"3","key":"10.1016\/j.canlet.2025.217512_bib48","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.tranon.2016.03.006","article-title":"Increased expression of PHGDH and prognostic significance in colorectal cancer","volume":"9","author":"Jia","year":"2016","journal-title":"Transl Oncol"},{"issue":"7","key":"10.1016\/j.canlet.2025.217512_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111233","article-title":"SHMT2-mediated mitochondrial serine metabolism drives 5-FU resistance by fueling nucleotide biosynthesis","volume":"40","author":"Pranzini","year":"2022","journal-title":"Cell Rep."},{"issue":"7360","key":"10.1016\/j.canlet.2025.217512_bib50","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nature10350","article-title":"Functional genomics reveal that the serine synthesis pathway is essential in breast cancer","volume":"476","author":"Possemato","year":"2011","journal-title":"Nature"},{"issue":"23","key":"10.1016\/j.canlet.2025.217512_bib51","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2022111550","article-title":"Non-canonical phosphoglycerate dehydrogenase activity promotes liver cancer growth via mitochondrial translation and respiratory metabolism","volume":"41","author":"Shu","year":"2022","journal-title":"EMBO J."},{"issue":"10","key":"10.1016\/j.canlet.2025.217512_bib52","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/s42255-021-00456-x","article-title":"The alternative activity of nuclear PHGDH contributes to tumour growth under nutrient stress","volume":"3","author":"Ma","year":"2021","journal-title":"Nat. Metab."},{"issue":"2","key":"10.1016\/j.canlet.2025.217512_bib53","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41573-021-00339-6","article-title":"Targeting cancer metabolism in the era of precision oncology","volume":"21","author":"Stine","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"issue":"8","key":"10.1016\/j.canlet.2025.217512_bib54","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.cmet.2023.07.006","article-title":"Emerging therapies in cancer metabolism","volume":"35","author":"Xiao","year":"2023","journal-title":"Cell Metab."},{"key":"10.1016\/j.canlet.2025.217512_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2021.100797","article-title":"Impact of cancer metabolism on therapy resistance - clinical implications","volume":"59","author":"Goncalves","year":"2021","journal-title":"Drug Resist Updat"},{"issue":"7","key":"10.1016\/j.canlet.2025.217512_bib56","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1038\/s12276-024-01268-1","article-title":"PHGDH: a novel therapeutic target in cancer","volume":"56","author":"Lee","year":"2024","journal-title":"Exp. Mol. Med."},{"issue":"1","key":"10.1016\/j.canlet.2025.217512_bib57","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41591-022-02103-8","article-title":"Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials","volume":"29","author":"Yap","year":"2023","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.canlet.2025.217512_bib58","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41591-022-02129-y","article-title":"Time to hit pause on mitochondria-targeting cancer therapies","volume":"29","author":"Zhang","year":"2023","journal-title":"Nat Med"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030438352500076X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030438352500076X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T22:56:58Z","timestamp":1760741818000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030438352500076X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":58,"alternative-id":["S030438352500076X"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2025.217512","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acidosis overrides molecular heterogeneity to shape therapeutically targetable metabolic phenotypes in colon cancers","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2025.217512","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"217512"}}